Table 1.
Baseline data (n = 198)
| Variables | Number or median (range) |
|---|---|
| Age (years) | 67.5 (22.6–89.8) |
| Gender, male/female | 108/90 |
| Body mass index (kg/m2) | 22.77 (13.05–36.61) |
| Serum myostatin (pg/mL), men | 3419.6 (578.4–12897.7) |
| Serum myostatin (pg/mL), women | 2662.4 (710.4–8782.0) |
| Psoas muscle index (cm2/m2), men | 5.33 (2.06–9.68) |
| Psoas muscle index (cm2/m2), women | 4.02 (0.79–6.70) |
| Causes of liver disease | 17/116/19/46 |
| HBV/HCV/alcoholic/others | |
| Child–Pugh classification, A/B/C | 123/72/3 |
| Presence of HCC, yes/no | 40/158 |
| Total bilirubin (mg/dL) | 1.1 (0.3–6.0) |
| Serum albumin (g/dL) | 3.6 (2.0–4.9) |
| Prothrombin time (%) | 74.7 (35.6–115.6) |
| Platelets (×104/mm3) | 8.6 (2.5–42.4) |
| Serum sodium (mmol/L) | 140 (127–145) |
| Serum creatinine (mg/dL) | 0.70 (0.34–4.14) |
| Total cholesterol (mg/dL) | 150 (70–306) |
| AST (IU/L) | 44 (16–402) |
| ALT (IU/L) | 34 (9–487) |
| Serum ammonia (μg/dL) | 40 (7–132) |
| HOMA‐IR | 2.51 (0.07–36.41) |
| BTR | 4.03 (1.46–9.67) |
| Ascites, yes/no | 35/163 |
| Alpha‐fetoprotein (ng/mL) | 5.5 (0.8–1345.0) |
Data are expressed as number or median (range). ALT, alanine aminotransferase; AST, aspartate aminotransferase; BTR, branched‐chain amino acid to tyrosine ratio; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; HOMA‐IR, homeostasis model assessment of insulin resistance.